Company_Context
Basic Materials
Pharmaceutical Preparations
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
7 directional transactions in 365D
Code P purchases and code S sales are measured from 2025.08.17 — 2026.08.16.
+$463K
Open-market buys minus sales2026.07.08
Latest available filing18
Reporting entities in windowParker Geoffrey M.
$307.3KNo 365D seller
No open-market sales in 365DAnalysis of eligible SEC Form 4 activity for PRGO indicates a bullish 365-day signal. The selected window contains transactions from 18 distinct reporting insiders, with aggregate nominal activity of $4.69M.
Open-market purchases minus open-market sales produce a positive net flow of $0.46M. Compensation-related awards and option exercises represent more nominal activity than directional open-market trades, so the signal should be interpreted cautiously.
The largest open-market purchase in the selected window was attributed to Parker Geoffrey M. (Director). Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Basic Materials
Pharmaceutical Preparations
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 365D headline signal window.
During the last 365 calendar days, Parker Geoffrey M. (Director) recorded the largest aggregate open-market purchase volume. Total insider buying in the window is $0.46M.
No eligible open-market sales were reported for PRGO during the last 365 calendar days.
The 365-day open-market signal is BULLISH, with net flow of $0.46M across 18 reporting insiders in the selected window.
Performance pending
No matured open-market transaction with calculated market windows is available in the recent sample.
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.